Strong data hygiene, formal governance, and human oversight are becoming essential to responsible, scalable AI adoption in clinical trials.
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance
Clear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.
-
More Than Document Collection: The eTMF As The Conductor Of Study Start-Up Part 1 – Site ID And Selection
In this post, gain insight into how the eTMF can mitigate the main drivers of delay in the site ID and Selection process.
-
How Flatiron Supported The Beat AML® Master Clinical Trial
Find out how the Leukemia and Lymphoma Society's partnership with Flatiron Health helped improve the Beat AML® Master Clinical Trial's data management and accelerate trial timelines.
-
Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops
As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.
-
Digital Advancements In Clinical Development - What's Next?
Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.
-
Sustainable Clinical Trials Through eClinical Innovation
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
Why Are Sponsor Organizations Using More Than 1 CTMS Solution?
Explore evolutions in the eClinical market, CTMS use in the outsourcing community, and the difficulty in keeping up with requirements that sponsor organizations, CROs, and clinical trial sites experience regarding their CTMS solutions.
-
CRO Takes Trial Build Times From Weeks To Days
Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.
-
Electronic Clinical Outcome Assessments (eCOA) In Clinical Trials
Manual outcome tracking creates compliance gaps and data quality risks. Electronic assessments help trial teams capture cleaner data, faster.
-
You Don't Have To Digitize Everything, You Just Have To Start
Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.
RECENT NEWSLETTERS
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks